ACCP Cardiology PRN
@accpcardprn
The @ACCP Cardiology PRN advances the pharmacotherapy of CV disorders through the promotion of excellence in education, research, and clinical practice.
ID:4213804032
http://www.accp.com 12-11-2015 15:49:13
3,9K Tweets
8,9K Followers
337 Following
Follow People
Our next #TeachingTuesday is brought to you by WakeMed's PGY-2 Cardiology Pharmacy Resident, Hannah Lunsford! Be sure to check out her infographic on DOACs in patients with a history of bariatric surgery next week! 🫀
It's #ThrowbackThursday as we review the POPular-AGE trial. This showed a significant reduction in bleeding and non-inferiority for net benefit with clopidogrel compared to ticagrelor for patients >70 with NSTEMI. Graphic by Ellie Kang at Texas A&M Pharmacy
pubmed.ncbi.nlm.nih.gov/32334703/
We are excited to highlight Vanderbilt Health 's PGY-2 Cardiology Pharmacy Resident Kennedy Manning 's CE on Anthracycline- Induced Cardiotoxicity! How does your institution monitor for this toxicity? Comment ⬇️
In this #JACCCardioOnc review, Dr. Mohamed Dabour, et al examine the established cardioprotective effects of #SGLT2i in #heartfailure & subsequently explore the existing body of evidence. bit.ly/4ccqRCd
#CardioOnc Zordoky_Lab Mina Y. George Mary Raphel Daniel Anne Blaes
It's #ThrowbackThursday ! Today we have the ACCOAST trial, which showed that pre-treatment with prasugrel prior to angiography doesn't reduce ischemic events but does increase the risk of bleeding. Graphic by Kennedy Manning at Vanderbilt Health
Read it here: pubmed.ncbi.nlm.nih.gov/23991622/
New data from #TRANSFORM_HF now in European Society of Cardiology Journals #EJHF
Across the spectrum of patient kidney function, no significant difference in clinical or patient-reported outcomes between torsemide and furosemide for treatment of HF.
Duke Clinical Research Institute Yale Cardiology
onlinelibrary.wiley.com/doi/full/10.10…